The EnTRy Program: Expanding Coordinated Specialty Care Beyond Early Psychosis.

This study aims to evaluate the quality and potential clinical benefits of a novel program, called the Enhanced Treatment and Recovery (EnTRy) Program, which provides Coordinated Specialty Care (CSC) without limits on diagnosis, age, or treatment time to individuals with serious mental illnesses (SMI). To assess recovery of participants, we compared the baseline Substance Abuse and Mental Health Services Administration (SAMSHA) National Outcome Measures (NOMs) in patients enrolled in EnTRy to that at 6 months and 12 months. To explore whether EnTRy provided benefits over standard treatment, we compared the time engaged in treatment for the EnTRy cohort with that of a historic sample from the same clinical site. Participants were significantly less likely to have a psychiatric hospitalization in the past 30 days during follow-up assessment at 6 months (19% at baseline, 1% at 6 months, (χ² (1, N = 1006) = 91, p<0.0001) and 12 months (16% at baseline, 1% at 12 months, χ² (1, N = 486) = 37.633, p<0.0001). Participants were similarly less likely to have psychiatric emergency service encounters in the past 30 days at 6 months (18% at baseline, 1% at 6 months, χ² (1, N = 1004) = 86.808, p < 0.0001) and at 12 months (16% at baseline, 2% at 12 months, χ²(1, N = 486) = 32.387, p= 0.0001). Patients enrolled in the EnTRy program remained engaged with care for significantly longer than a historical sample (p< 0.0001 by Mantel-Cox logrank) with a logrank hazard ratio of 2.0 (CI 1.65- 2.43). Age and diagnosis-unlimited CSC may be particularly effective for individuals with SMI who recently received hospital level care and may help maintain gains in individuals who have aged out of programs dedicated to first episode psychiatric illness.